Track the Acutus Medical, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Acutus Medical, Inc. has recorded 71 insider filings. Market capitalisation: €3k. The latest transaction was disclosed on 4 March 2024 (Retenue fiscale). Among the most active insiders: Roman David. Every trade is openly available.
71
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
1 ops.
Sell Volume
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,099 of 29,062 companies
18.1
score / 100
Value
33
Quality
3
FCF yld·
Earn yld·
EV/EBITDA15.9x
ROE·
Gross mgn5.0%
Net mgn-47%
Debt/EBITDA15.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,165 shares@ US$0.7545.3% of flowFORM 4SEC:0001628280-23-010611:0
25 of 71 declarations
About Acutus Medical, Inc.
Acutus Medical, Inc. is a company focused on developing technologies for the diagnosis and treatment of heart diseases. It is listed on NASDAQ under the ticker symbol ACUS.